Semaglutide vs. Tirzepatide: What's the Difference?

If you've started researching medical weight loss, you've probably run into two names over and over: semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Both are weekly medications, both quiet appetite, and both can lead to meaningful weight loss. So what actually separates them?

Here's a plain-language comparison of how they work, what the research shows, and how I help patients decide which one fits. If you'd like the basics of how this class of medication affects appetite and blood sugar first, start with my post on how GLP-1 medications work for weight loss.

1. One Hormone vs. Two

The core difference is in how each medication works. Semaglutide mimics one gut hormone, GLP-1 (glucagon-like peptide-1), which helps you feel full sooner, slows digestion, and supports healthy blood sugar.

Tirzepatide mimics GLP-1 and a second gut hormone, GIP (glucose-dependent insulinotropic polypeptide). GIP also plays a role in blood sugar regulation and energy balance. Acting on both pathways is thought to be part of why tirzepatide tends to produce greater weight loss on average.

2. What the Research Shows

In 2025, the two medications were compared directly in a large clinical trial called SURMOUNT-5, published in the New England Journal of Medicine. Adults with obesity (without diabetes) took the highest dose they tolerated of either medication for 72 weeks. Those on tirzepatide lost an average of 20.2% of their body weight, compared with 13.7% on semaglutide.

Tirzepatide users were also more likely to reach bigger milestones: nearly half lost at least 20% of their body weight, compared with about a quarter of those on semaglutide.

Averages aren't guarantees, though. Plenty of people do very well on semaglutide, and some respond better to one medication than the other. Your history, how you tolerate side effects, and your goals all matter.

3. Side Effects Are Similar

Both medications share the same common side effects, mostly digestive: nausea, bloating, constipation, diarrhea, or reflux. These are usually mild to moderate and most noticeable when starting or increasing a dose, which is why we increase gradually.

Some people tolerate one medication better than the other, so switching is always an option if side effects get in the way. Eating smaller meals, slowing down, staying hydrated, and avoiding very greasy foods help with either one.

4. Pill vs. Injection

Both are typically given as a once-weekly injection with a small pen. Semaglutide is now also available as a once-daily pill (the Wegovy pill), approved by the FDA for weight management in late 2025. In its main trial, people who took it consistently lost an average of about 16.6% of their body weight.

The pill can be a great fit for people who'd rather avoid needles, but it comes with rules: it's taken on an empty stomach with a small sip of water, then you wait before eating or drinking. Some people find a weekly injection easier to stick with than a daily routine.

5. Other Things to Weigh

• Heart health: semaglutide (Wegovy) is FDA-approved to reduce the risk of major cardiovascular events in people with overweight or obesity and existing heart disease.
• Cost and coverage: pricing and insurance coverage vary widely and change often, so this is worth checking for your specific plan.
• Your health history: neither medication is recommended for people with a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or who are pregnant or trying to conceive.

6. Whichever You Choose, the Basics Still Matter

Both medications reduce appetite, so you'll naturally eat less. Without enough protein and regular strength training, some of the weight lost can come from muscle. Protecting muscle matters for metabolism, energy, and long-term health. Grip strength is one simple way to track it.

Before starting either medication, I review your health history and blood work so we can choose safely and track progress over time. For more on preparing, read what to know before starting GLP-1 weight loss treatment.

The Bottom Line

Semaglutide acts on one appetite hormone; tirzepatide acts on two and, on average, leads to more weight loss. Side effects are similar, semaglutide comes in pill form, and the best choice depends on your health, goals, and how your body responds.

If you're itrying to decide between them, schedule a consultation at Inject SkinCare. We'll review your labs, talk through your options, and build a medically supervised plan around you.